Meiji/KM Biologics’ 5-in-1 Vaccine Now Available Ahead of NIP Rollout

March 15, 2024
Meiji Seika Pharma and KM Biologics, both Meiji group companies, said on March 14 they have launched Quintovac, a five-in-one combination vaccine against pertussis, diphtheria, tetanus, polio, and Hib (DTaP-IPV-Hib vaccine), in Japan the same day. The launch comes just...read more